End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18
Richard Pebody(National Security Agency), Maria Zambon(Public Health England), Muhammad Sartaj(Public Health Agency), Jim McMenamin(Public Health Scotland), Diogo Marques(Public Health Scotland), Rory Gunson(NHS Greater Glasgow and Clyde), Chris Robertson(University of Strathclyde), Samantha J. Shepherd, Katja Höschler(National Security Agency), Mary Sinnathamby(Public Health England), Catherine Moore(University of Oxford), Abdelmajid Djennad(Public Health England), Nikolaos Panagiotopoulos(Public Health England), Mónica Galiano(Public Health England), Mark G. O’Doherty(Public Health Agency), Angie Lackenby(Public Health England), Nick Andrews(Environment Agency), Matthew Donati(Public Health England), Joanna Ellis(Public Health England), Simon Cottrell(Public Health Wales), Rebecca Webb(City, University of London), Ivelina Yonova(University of Surrey), Arlene Reynolds(Health Protection Scotland), Simon de Lusignan(University of Oxford)
Cited by 50
Related Papers
Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group
|Journal of Virology|2013|1.3k
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome
|The Lancet|2003|1.1k
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
|Nature Microbiology|2022|724